Clinical trial
Intratumoral Ipilimumab in Head and Neck Cancer
NCT02812524 is registered in ClinicalTrials.gov with Providence Health & Services as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Intratumoral Ipilimumab in Head and Neck Cancer
- Lead sponsor
- Providence Health & Services
- Phase
- Phase 1
- Overall status
- Active, not recruiting
- Start date
- November 18, 2016
- Completion date
- December 31, 2026
- Enrollment
- 18 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
squamous cell carcinoma of the head and neck